FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical combination and to pharmaceutical composition and, in particular, to combination of analgesic and anti-inflammatory agent, selected from ketorolac and meloxicam, and pharmaceutically acceptable carriers or excipients.
EFFECT: present invention also relates to use of said composition for preparation of drug, which can be used for treating pain and inflammation.
11 cl, 2 ex, 9 tbl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TAPENTADOL COMPOSITIONS FOR PAIN MANAGEMENT | 2008 |
|
RU2497512C2 |
| PARENTERAL COMPOSITIONS AND THEIR APPLICATION | 2015 |
|
RU2744987C2 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2259204C1 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
| MULTICOMPONENT COMPOSITION FOR USE IN ELIMINATING INFLAMMATION | 2019 |
|
RU2816699C2 |
| TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS | 2020 |
|
RU2742879C1 |
| ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS | 2013 |
|
RU2657556C2 |
| SYNERGETIC ANALGETIC COMBINATION OF OPIOID ANALGETIC AGENT AND CYCLOOXYGENASE-2 INHIBITOR | 1998 |
|
RU2232600C2 |
| PIROXICAM-CONTAINING ANTI-INFLAMMATORY COMPOSITIONS FOR TOPICAL USE, METHOD OF SOLUBILIZATION OF PIROXICAM | 1995 |
|
RU2138266C1 |
